Biotech · Private company
PharPoint Research, Inc.
Track this companyFree. Adds PharPoint Research, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials72 recruiting or active
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Clinical trials7
- A First in Human Study of the Safety, Tolerability, and the Physiologically Based Pharmacokinetics of XFB19 in Healthy Adult Volunteers.PHASE1 · RECRUITING · started Feb 17, 2026ClinicalTrials.gov NCT05361733 · fetched Nov 12, 2026
- 855303-RNA Biomarker ValidationENROLLING_BY_INVITATION · started Aug 25, 2025ClinicalTrials.gov NCT06872775 · fetched Nov 12, 2026
- Safety and Efficacy of Albuterol Administered by the Halix™ Dry Powder Inhaler in Subjects With AsthmaPHASE2 · COMPLETED · started Jun 30, 2018ClinicalTrials.gov NCT03643874 · fetched Nov 12, 2026
- Study to Evaluate the Efficacy, Safety, and Tolerability of Topical VDA-1102 Ointment in Subjects With Actinic KeratosisPHASE2 · COMPLETED · started May 23, 2018ClinicalTrials.gov NCT03538951 · fetched Nov 12, 2026
- Gelclair at Conditioning or After Oral Mucositis Diagnosed vs. Magic Mouth Wash in Stem Cell Transplant RecipientsPHASE4 · TERMINATED · started May 15, 2018ClinicalTrials.gov NCT03490396 · fetched Nov 12, 2026
- Safety and Pharmacokinetics of Halix(TM) Albuterol Unit Dose Disposable Inhaler Versus Albuterol MDIPHASE1 · COMPLETED · started Nov 30, 2017ClinicalTrials.gov NCT03373409 · fetched Nov 12, 2026
- A Proof of Concept Study to Evaluate CN-105 in ICH PatientsPHASE2 · COMPLETED · started Aug 28, 2017ClinicalTrials.gov NCT03168581 · fetched Nov 12, 2026